Legends Business Group Inc (LGBS)

[Prosper/high]

$LGBS Big News Legends Business Group Inc Making Big Moves development and testing of various alternative and exotic energy products for marketing to the general public through a manufacturing partner or licensee.
– Manufacturing and/or testing various battery charging products for which it has applied for patent protection. The Company focuses on manufacturing (either internally or through a partner) and marketing these battery products.” Source

The alternative energy sector and the development of patents for manufacturing are exciting activities that, at this point in time, are bringing interesting returns to the market participants. We have also reviewed other companies operating the same businesses. Market participants can check, for example, Dolat Ventures Inc., which focuses on the development of batteries for “New Energy Vehicles”, or Mass Megawatts Wind Power Inc, the energy systems company developing environmentally-friendly technologies. By checking these articles, market participants will be able to understand the positive reaction in the share price that caused the new developments of companies operating in those sectors. LGBS’ management has demonstrated its capabilities, being quite smart, by opting to enter into these industries.

Recent news and Financial perspective

On June 14, 2017, the company announced that it would commence a “Brand New Era“. Why? A new CEO with expertise in the oil and gas sector was about to be elected. On June 20, 2017, the new business executive was introduced to the market:

“Brian Estrada was appointed as Chief Executive Officer of the company. Estrada brings with him knowledge and background in the Oil & Gas sector for the company moving forward.” Source

Let’s review the financial statements. The company had not yet reported the revenues, thus we will focus on the BS. The following are the most important assets and liabilities of LGBS from the last quarterly report:

Developments Costs: $440,000
Intellectual Property: $85,000
Marketable securities: $30,000
Notes Payable: $790,000
Additionally, there is an interesting account to mark in this company. The accumulated deficit is $9,541,112. What does it mean? These are Non operating losses, which will be tax deductible for the company. Once the company acquires businesses that report revenues, the amount of taxes paid will be less because of this NOLs. The following text is from the Investopedia:

“A net operating loss (NOL) is a loss taken in a period where a company’s allowable tax deductions are greater than its taxable income. When more expenses than revenues are incurred during the period, the net operating loss for the company can generally be used to recover past tax payments.” Source

Is this a normal practice? Yes, holding companies usually chose business entities with large deficits.

Biggest Catalyst and Conclusion

Undoubtedly, the biggest catalyst is the company’s entrance into the Oil and Gas sector and the election of the new CEO. These are very recent events that many not have been fully incorporated into the share price. Entering a new market means that the company will be able to compete in another domain, thus potential revenues increase. In addition, a new face in the company will probably bring about a lot of changes. The new executive may want to create new teams, increase efficiency, and the company’s flexibility. This is always good for the organization. Market participants may believe that the new changes are a good reason to buy shares of the company. If enough market participants act in this way, the share price may creep up. Hence, we encourage email subscribers to be alert regarding the price action. Additionally, we expect the new CEO to release new corporate developments, thus check the company announcements as they happen.

We will be updating our subscribers as soon as we know more. For the latest updates on LGBS, sign up below!

Image courtesy of Flickr

Disclosure: We have no position in LGBS and have not been compensated for this article.


GET NOTIFIED

Sign up for our next MicroCap Runner ahead of the crowd!
We hate spam. No Hidden Fees. Unsubscribe Anytime.
RELATED ITEMS:LEGENDS BUSINESS GROUP INC, LGBS, OIL AND GAS RECOMMENDED FOR YOU
Elite Group Inc (OTCMKTS:ELTZ) On The Verge Of A Breakout PETRO RIVER OIL CO COM USD0.00001 (POST REV SP (OTCBB:PTRC) Making Smart Moves Linn Energy Inc (OTCMKTS:LNGG) Too Cheap To Ignore CLICK TO COMMENT CANNABIS CV Sciences Inc (OTCMKTS:CVSI) Looking To Overcome Headwinds
ByRichard SandlePosted on June 26, 2017

When we last reviewed CV Sciences, Inc (OTCMKTS:CVSI) on June 9 2017, we mentioned that the Company had an upcoming meeting with the U.S. Food and Drug Administration (FDA) on June 15, 2017, to discuss its initial drug candidate (CVSI-007), a chewing gum that combines plant-based cannabidiol (CBD) and nicotine for the purpose of treading smokeless tobacco addiction. The meeting did take place and had positive results. However, since then, the Securities and Exchange Commission (SEC) has filed fraud charge against the Company and CEO Michael Mona Jr.

Before we get into the details, a little background for those not familiar with CV Sciences, Inc. The company operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic cannabidiol (CBD); and a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in Las Vegas, Nevada and San Diego, California. The company has pivoted into drug development focused on the development and commercialization of cannabis derived innovative medicines.

The SEC Complaint filed on June 16, 2016 alleges that CannaVEST Corp. (now known as CV Sciences, Inc.) and CEO Michael Mona Jr. materially overstated the company’s total assets in quarterly reports for the first and second quarters of 2013.

According to the complaint, CannaVEST reported purchasing a company called PhytoSphere Systems LLC, including its existing rights under contracts with hemp production and processing facilities, for $35 million, even though Mona knew that the purported purchase price was substantially inflated. The complaint alleges that CannaVEST agreed to the purported purchase price only because CannaVEST could pay for the acquisition primarily with CannaVEST shares which Mona believed had little value at the time.

The complaint further alleges that in the third quarter of 2013, CannaVEST obtained a third-party valuation of PhytoSphere for $8 million as of the date CannaVest acquired PhytoSphere. The complaint charges CannaVEST with fraud, filing false financial reports, and other federal securities law violations, and seeks a permanent injunction and civil money penalties. The complaint also charges CEO Michael Mona Jr. with fraud and other violations, including the deceit of auditors, and seeks a permanent injunction, civil money penalties, an officer and director bar, and reimbursement of his $10,000 cash bonus for 2013, as provided for under Section 304(a) of the Sarbanes-Oxley Act.

Mr. Mona immediately responded to the complaint on June 19, 2017 in a letter to the Company’s shareholders and customers. In the letter, Mr. Mona explains that the complaint relates to the acquisition of the assets of PhytoSphere Systems, LLC in January 2013, including the seller’s European inventory supply chain which was the asset critical in launching the Company’s successful consumer products division. Mr. Mona further states in the letter:

“the SEC does not question the legality of the transaction nor does the SEC criticize our operations. Further, the SEC does not suggest that any officer or director sold shares of stock in connection with this transaction, or at any other time. The SEC simply takes issue with how the Company reported the transaction in its quarterly reports to the SEC during the first three quarters of 2013. More specifically, with the benefit of hindsight, the SEC takes issue with the negotiated acquisition price and the timing of our valuation to determine asset reporting value.”

The Company has retained Paul Hastings as litigation counsel and intends to vigorously defend this matter.

In other positive news on June 19, 2017, the Company announced that it held its pre-IND meeting with the U.S. Food and Drug Administration (FDA) on June 15, 2017, to review its drug development plan for CVSI-007, the Company’s patent-pending product for smokeless tobacco addiction therapy. CEO Michael J. Mona, Jr. commented:

“Our pre-IND meeting with the FDA was very constructive and provided the Company with a favorable development roadmap for this important combination drug candidate. We have immediately commenced preparation of our Investigational New Drug application (IND) to initiate human trials. Our New Drug Application will be under the 505(b)2 pathway using nicotine-polacrilex gum, an FDA-approved nicotine replacement therapy”



CVSI stock has been hovering near a support level around $.27. On Monday, June 19, 2017, the first trading day after the SEC made its announcement, the stock gapped down from $.2950 to $.2650, and closed at $.2397. The stock seems to have stabilized and is currently trading at $.2307. Current market capitalization is holding at $20.52 million, on 88.95 million shares outstanding as of June 23, 2017.

Although the stock price did dip a little, the adverse news of the SEC complaint, and the favorable news of the FDA meeting seem to have countered each other. There will be however, lingering effects from both news events, both positive and negative. We will be watching closely to see if CVSI prevails. We will be updating our subscribers as soon as we know more. For the latest updates on CVSI, sign up below!

Image courtesy of Flickr

Disclosure: We have no position in CVSI and have not been compensated for this article.

GET NOTIFIED

Sign up for our next MicroCap Runner ahead of the crowd!
We hate spam. No Hidden Fees. Unsubscribe Anytime.
RELATED ITEMS:CV SCIENCES INC, CVSI RECOMMENDED FOR YOU
CV Sciences Inc (OTCMKTS:CVSI) Preparing To Fill An Untapped Market CLICK TO COMMENT
MOST POPULAR CANNABIS3 Ways Trump Immigration Order Is Affecting Alphabet Inc (NASDAQ:GOOGL) And Others
Enter Symbol For Report



CANNABISGet Out Of Hemp Inc (OTCMKTS:HEMP) While You Can CANNABISPernix Therapeutics Holdings Inc (NASDAQ:PTX) About To Be Bought Out? CANNABISAmerican Green Inc (OTCMKTS:ERBB) Banking On Green Rush 2.0
Insider Financial
For over five years, we have provided a free service to a countless number of traders featuring only the best in the microcap arena. Insider Financial focuses solely on short-term high probability trade opportunities.

Our alerts consist of Nasdaq, NYSE and high quality OTC companies that are capable of delivering outsized gains to you today, not a year from now. If you have an interest in the lucrative microcap sector, sign up to Insider Financial today!

COMPANY
Privacy Policy
Feedback
Advertising
Contacts
About Insider Financial
Writing Staff
Disclaimer
GET NOTIFIED

Sign up for our next MicroCap Runner ahead of the crowd!
We hate spam. No Hidden Fees. Unsubscribe Anytime.
CANNABIS BIOTECH & PHARMA ENERGY & SOLAR STOCKS MOMENTUM STOCKS
Copyright © 2017 Insider Financial powered by Hundred.


https://insiderfinancial.com/legends-business-group-inc-otcmktslgbs-making-big-moves